ATEX vs TECH · P/E 16, rev $6.0M vs P/E 65, rev $1.22B
Anterix Inc (ATEX) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Anterix Inc (ATEX) is a telecom services company listed on NASDAQ.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported ATEX revenue for 2025-03-31 was $6.0M. Net income was -$11.4M. Revenue was up 43.9% from 2024-03-31 to 2025-03-31. ATEX currently screens at market cap $1.50B and trailing P/E 16.4.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
ATEX currently screens at market cap $1.50B and trailing P/E 16.4. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the ATEX and TECH stock pages for the full models.
Not investment advice.